“Ineffective drugs have a profound impact on patients. First of all, the patient could be taking a medication that not only doesn’t make them feel better, but could also result in unwanted adverse effects. Establishing a way to ensure patients are prescribed optimal treatment from day one while avoiding adverse effects and the billions of dollars that payers and patients waste each year on ineffective treatments is key to combating this dilemma.
We recently spoke to Alif Saleh, CEO of Scipher Medicine to learn how RNA data from a patient’s blood sample can be used to determine the underlying molecular processes driving a disease, and establish how well a patient will respond to a particular therapy.”
